Research ArticleNuclear Oncology
Fluorine-18-Fluorodeoxyglucose and Carbon-11-Methionine Evaluation of Lymphadenopathy in Sarcoidosis
Yoshihito Yamada, Yoshitaka Uchida, Koichiro Tatsumi, Tetsuo Yamaguchi, Hiroshi Kimura, Hiroshi Kitahara and Takayuki Kuriyama
Journal of Nuclear Medicine July 1998, 39 (7) 1160-1166;
Yoshihito Yamada
Yoshitaka Uchida
Koichiro Tatsumi
Tetsuo Yamaguchi
Hiroshi Kimura
Hiroshi Kitahara


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Fluorine-18-Fluorodeoxyglucose and Carbon-11-Methionine Evaluation of Lymphadenopathy in Sarcoidosis
Yoshihito Yamada, Yoshitaka Uchida, Koichiro Tatsumi, Tetsuo Yamaguchi, Hiroshi Kimura, Hiroshi Kitahara, Takayuki Kuriyama
Journal of Nuclear Medicine Jul 1998, 39 (7) 1160-1166;
Jump to section
Related Articles
- No related articles found.
Cited By...
- PET/CT in nononcological lung diseases: current applications and future perspectives
- EANM/SNMMI Guideline for 18F-FDG Use in Inflammation and Infection
- Tumor Cell Metabolism Imaging
- Usefulness of 11C-Methionine for Differentiating Tumors from Granulomas in Experimental Rat Models: A Comparison with 18F-FDG and 18F-FLT
- Comparative Evaluation of 18F-FDG PET and 67Ga Scintigraphy in Patients with Sarcoidosis
- Variable Problems in Lymphomas: CASE 2. Sarcoidosis Mimicking Progressive Lymphoma
- Imaging DNA Synthesis In Vivo with 18F-FMAU and PET
- Is 18F-3'-Fluoro-3'-Deoxy-L-Thymidine Useful for the Staging and Restaging of Non-Small Cell Lung Cancer?
- 3'-18F-Fluoro-3'-Deoxy-L-Thymidine: A New Tracer for Staging Metastatic Melanoma?
- Nodal Staging of Lymphoma with Whole-Body PET: Comparison of [11C]Methionine and FDG